Gianluca Pontone is an expert in Cardiology at Centro Cardiologico Monzino (Italy). As of October 2026, ScienceLeadR ranks Gianluca Pontone in the top 1% of experts worldwide for Coronary Disease, Arterial Occlusive Diseases and Arteriosclerosis. Gianluca Pontone has authored 1,095 publications, the most recent in 2026, and is an investigator in 41 clinical trials, 19 of them ongoing. SLR score: 4,089 (community average: 125). How the SLR is computed.

LeadR Profile

Gianluca Pontone Centro Cardiologico Monzino Italy
4 089 ScienceLeadR Reputation 4089
Network Map

Cardiology

Subspecialties: Medical Imaging - Informatics - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Prof. Gianluca Pontone was graduated with honors in medicine in 1997 followed by post-graduate degree in cardiology and radiology and PhD in Clinical Methodology in 2001, 2006 and 2014 at University of Milan, Italy. He is currently Deputy Scientific Director and Director of Perioperative Cardiology and Cardiovascular Imaging Department and Co-director of Sport Cardiology Unit of Centro Cardiologico Monzino, a fully dedicated research hospital to cardiovascular disease and Professor of Cardiology at University of Milan. He is author of more than 650 indexed articles on international journal with an overall H-index of 69. He is currently chairman of EACVI Industry committee, EACVI board member and chairman of Italian Working group of Cardiovascular Imaging of Italian Society of cardiology. He is also associate editor of JACC, EHJCI, JCCT, Atherosclerosis and Eurointervention


Organizations

Career arc: 2000 - 2026

Source: PubMed

University of Milan

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Real-world implementation of ESC guidelines in chronic coronary syndromes: Insights from the EURECA registry with a focus on Italian practice.
PMID 42744020 — registries, exercise, angiography, cardiology, ischemia
Int J Cardiol20260
DAPAgliflozin-Related Cardiac REverse Remodeling by 2D and 3D Echocardiography in OptiMally Treated HFrEF Patients: The DAPA-REM Study.
PMID 42927625 — heart failure, heart, heart failure, systolic, echocardiography, therapeutics, echocardiography, three-dimensional
Echocardiography20260
Patient-Level Perivascular Adipose Tissue Density Aggregation and Plaque Progression: Plaque-Free vs Plaque-Adjacent Segments.
PMID 42900033 — research design, coronary artery disease, tissues, adipose tissue
JACC Cardiovasc Imaging20261
Whole heart atherosclerosis volume and risk for major adverse cardiovascular events across the clinical likelihood for obstructive CAD; the CONFIRM2 study.
PMID 42893061 — stroke, incidence, heart, angiography, atherosclerosis
Am J Prev Cardiol20261
The interplay of coronary serial stenoses and their deceptive impact on hemodynamic and surgical planning.
PMID 42892260 — constriction, pathologic, computers, angioplasty, arteries, work, software, wounds and injuries, hemodynamics
Comput Methods Programs Biomed20260

Clinical Studies 41

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 6 Study Director: 1

By phase:

N/A 35
Phase 3 4
Phase 2 1
Phase 4 1

By status:

Recruiting 17
Completed 13
Active not recruiting 4
Unknown 4
Enrolling by invitation 1
Not yet recruiting 1
Terminated 1

By type:

Observational 26
Interventional 15

By Monocentric/Multicentric:

monocentric 21
multicentric2to4 3
multicentric5to9 2
multicentricup10 15

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

19 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Phase III Prospective Multicenter Open label Study to Assess Diagnostic Efficacy of a Novel 18F labelled Tracer SYN2 for Positron Emission Tomography in Subjects with Suspected Coronary Artery Disease
2023-506971-89-00 — coronary artery disease, tomography, positron-emission tomography, arteries
Phase 3Recruiting2024
Radiomics Analysis of CMR Imaging for Arrhythmic Risk Prediction in Hypertrophic Cardiomyopathy With Longitudinal Risk Reassessment After Mavacamten Therapy in Obstructive Patients
NCT07695272 — myosins, fibrosis, cardiomyopathy, hypertrophic, signs and symptoms, cardiac myosins, therapeutics, cardiomyopathies
N/AActive not recruiting2026
OCEAN(a) CCTA Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction Coronary Computed Tomography Angiography trial
2025-521117-88-00 — safety, tomography, lipoproteins, cardiovascular diseases, multiple chronic conditions, angiography, arteries, lipoprotein(a), computed tomography angiography
Phase 3Recruiting2026
Insights From the FAST TRACK CABG Trial a Clinical Outcome Study in Patient With Previous Surgical Revascularization for Complex Three vessel or Left Main Coronary Artery Disease Based on Coronary Computed Tomography Angiogram and Fractional Flow Reserve Derived by Computed Tomography
NCT07628270 — serum, coronary artery disease, tomography, lipoproteins, angiography, arteries, coronary artery bypass, lipoprotein(a)
N/ARecruiting2025
Derivation and Validation of the Aortic Valve Echocardiographic Calcium Score to Confirm Severe Aortic Stenosis the Echo AVCS Study
NCT07620925 — constriction, pathologic, intelligence, aortic valve stenosis, pharmaceutical preparations, tomography, drugs, investigational, aortic valve, calcium, physicians, echocardiography, aortic valve disease, therapeutics, software, artificial intelligence
N/ARecruiting2026

LeadR Networks

Main global connection map